Skip to Content

CCIR Distinguished Seminar Series

Invited Speakers for Fiscal Years 2012 and 2013 

  • November 10, 2011:  "Frontiers in Therapeutic Manipulation of the Tumor Microenvironment:  the Case of the PD1 Pathway" Drew Pardoll, M.D., Ph.D., Johns Hopkins University
  • December 8, 2011:  "Deconstructing Cancer Immunoediting"  Robert Schreiber, Ph.D., Washington University
  • January 5, 2012:  "Generating and Maintaining Memory CD8 T Cells" John Harty, Ph.D., University of Iowa

  • February 15, 2012:  "Taking T Cell Therapies to Phase 3 and Licensure"  Cliona Rooney, Ph.D., Baylor College of Medicine
  • March 1, 2012:  "Alternative Pathways for Memory CD8 T Cell Generation" Stephen Jameson, Ph.D., University of Minnesota
  • April 5, 2012:  "T Cell Traffic and Retention:  Challenges and Opportunities for Immune Therapy of Melanoma" Craig Slingluff, M.D., University of Virginia
  • May 3, 2012:  "Targeting Foxp3+ Treg Cells to Promote Host Anti-tumor Immune Responses" Wayne Hancock, M.D., Ph.D., University of Pennsylvania
  • June 7, 2012:  "Roles of TRAFs in the Regulation of B-cell Function and Malignancy" Gail Bishop, Ph.D., University of Iowa
  • October 31, 2012:  "Origins of CD4+ Memory T Cells" Marc Jenkins, Ph.D., University of Minnesota Medical School
  • November 14, 2012:  "Exosomes:  Mediators and Biomarkers of Disease" Douglas Taylor, Ph.D., University of Louisville
  • December 6, 2012:  "Innate and Adaptive Immunity Regulated within the Tumor Microenvironment"  Thomas Gajewski, M.D., Ph.D., University of Chicago
  • January 10, 2013:  "Immunoregulation of Graft-versus-Host Disease"  Bruce Blazer, M.D., University of Minnesota

Highlights

  • 2011 Dallas-Fort Worth Living Legends

    Robert Coffman, Ph.D., of Dynavax Technologies

    "Development of vaccine adjuvants and novel therapeutics for autoimmune disease by regulating toll-like receptor activity"

  • 2011 R.E. "Bob" Smith Lecture

    Max Cooper, M.D., of Emory University School of Medicine

    "Ancient antibodies against cancer cells"

  • 2011 R.E. "Bob" Smith Lecture

    Tasuku Honjo, M.D., Ph.D., of Kyoto University School of Medicine

    "Dilemma of AID:  Infection or Cancer"

  • 2010 R.E. "Bob" Smith Lecture

    Bob Beutler, M.D., of The Scripps Research Institute

    "Sensing Infection"

  • 2008 Dallas/Ft. Worth Living Legends Professorship

    Jacques Banchereau, Ph.D., of  Baylor Institute for Immunology Research

    "Taking dendritic cells into medicine"

  • 2008 R.E. "Bob" Smith Lecture

    K. Frank Austen, M.D., of Harvard Medical School

    "Developmental biology and effector functions of mast cells"

  • 2007 R.E. "Bob" Smith Lecture

    Shimon Sakaguchi, M.D., Ph.D., of Kyoto University

    "Regulatory T cells in immunological self-tolerance"

  • 2006 R.E. "Bob" Smith Lecture

    Dan Littman, M.D., Ph.D., of New York University

    "Transcriptional networks in the regulation of inflammatory cells"

  • 2005 R.E. "Bob" Smith Lecture

    Lewis Lanier, Ph.D., of University of California - San Francisco

    "NK receptors in innate immune responses"

  • 2004 R.E. "Bob" Smith Lecture

    Hugh McDevitt, M.D., of Stanford University

    "T cells and dendritic cells in the initiation of type 1 diabetes mellitus"

Previously Invited Speakers

2004

2005

2006

2007

2008

2009

2010

2011

(click the year for a pdf of scheduled presentations)


© 2013 The University of Texas MD Anderson Cancer Center